# Regeneron Pharmaceuticals Inc. (REGN) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $3.58B |
| 2024 | $3.99B |
| 2023 | $4.05B |
| 2022 | $4.74B |
| 2021 | $8.95B |
| 2020 | $3.58B |
| 2019 | $2.21B |
| 2018 | $2.53B |
| 2017 | $2.08B |
| 2016 | $1.33B |
| 2015 | $1.25B |
| 2014 | $824M |
| 2013 | $743M |
| 2012 | $458M |
| 2011 | -$205M |
| 2010 | -$97M |
| 2009 | -$74M |
| 2008 | -$86M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $643M |
| 2025-09-30 | $1.03B |
| 2025-06-30 | $1.08B |
| 2025-03-31 | $592M |
| 2024-09-30 | $1.18B |
| 2024-06-30 | $1.07B |
| 2024-03-31 | $751M |
| 2023-09-30 | $1.11B |
| 2023-06-30 | $1.02B |
| 2023-03-31 | $947M |
| 2022-09-30 | $1.22B |
| 2022-06-30 | $1.11B |
| 2022-03-31 | $1.26B |
| 2021-09-30 | $1.85B |
| 2021-06-30 | $3.35B |
| 2021-03-31 | $1.11B |
| 2020-09-30 | $1.05B |
| 2020-06-30 | $656M |
| 2020-03-31 | $700M |
| 2019-09-30 | $739M |
| 2019-06-30 | $316M |
| 2019-03-31 | $480M |
| 2018-09-30 | $627M |
| 2018-06-30 | $622M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/REGN/operating-income)